
For many women, uterine fibroids are an unseen battle, one that quietly reshapes daily life through heavy menstrual bleeding, pelvic pressure, fatigue, and emotional distress. Though fibroids are benign growths that develop in or on the uterus, their effects are often anything but harmless. In Kenya and around the world, women have long endured the discomfort, sometimes believing that hysterectomy, the surgical removal of the uterus, is their only option. But medicine has evolved, and with it has come a gentler, uterus-preserving alternative known as Uterine Fibroid Embolization, or UFE.
Fibroids are non-cancerous growths that develop from the muscle layer of the uterus and can appear in different locations, inside the uterine wall, bulging into the cavity, or projecting outward into the pelvis. Though their exact cause remains uncertain, hormones such as estrogen and progesterone play a major role in their development, and genetics often influence whether a woman is predisposed to them. Interestingly, fibroids tend to shrink after menopause when hormonal activity declines.
When it comes to treatment, there are four main approaches depending on the size of the fibroids, their location, and the symptoms a woman experiences. The first is watchful waiting, suitable for women nearing menopause or those with mild symptoms, since fibroids often shrink naturally when hormone levels drop. The second approach is medical therapy, which uses hormonal medication to reduce bleeding or temporarily shrink fibroids, though symptoms often return once treatment stops. The third is surgery, which can be either a myomectomy (removing only the fibroids and preserving the uterus) or a hysterectomy (removing the uterus completely). The fourth, and often least understood, is uterine fibroid embolization, a minimally invasive procedure that has changed the treatment landscape for many women.
UFE works by cutting off the blood supply to the fibroids, causing them to shrink and die off gradually. Unlike surgery, it requires only a tiny incision, about a millimeter wide, on the wrist or near the elbow joint. Through this small entry point, a thin catheter is guided using imaging technology into the arteries that feed the fibroids. Once in place, the doctor releases microscopic particles that block these blood vessels, starving the fibroids of oxygen and nutrients.
The procedure doesn’t require general anesthesia or hospital admission, most patients go home the same day, and within ten to fourteen days, they are back to work and living their normal lives.
This short recovery time, combined with the fact that the uterus is preserved, makes UFE a highly appealing option for women who want to avoid major surgery. It offers a pathway to healing that’s less invasive but equally effective in restoring comfort and confidence.
